Furthermore, these findings suggest that the intracellular function of EMAP II possibly antagonizes its extracellular anti-angiogenic functions during fetal development [19], [21], pulmonary disease progression [22], [23], [34], and wound healing [24]. The gene discussed is AIMP1; the disease is lung disorder.